News Releases

Nov 16, 2021 Pulmonx to Present at the 33rd Annual Piper Sandler Healthcare Conference
REDWOOD CITY, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) --  Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will participate in the 33 rd Annual Piper Sandler Healthcare Conference being held from
Nov 03, 2021 Pulmonx to Participate at Upcoming Investor Conferences
REDWOOD CITY, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in two upcoming virtual investor conferences.
Nov 02, 2021 Pulmonx Reports Third Quarter 2021 Financial Results
REDWOOD CITY, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for severe lung disease, today reported financial results for the third quarter ended September 30, 2021.
Oct 26, 2021 Pulmonx to Report Third Quarter 2021 Financial Results on November 2, 2021
REDWOOD CITY, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the third quarter of 2021 after the close of trading on Tuesday,
Sep 21, 2021 Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment
Blue Cross Blue Shield of Michigan and Horizon Blue Cross Blue Shield of New Jersey Issue Coverage Policies Providing Coverage for Treatment with the Zephyr® Valve REDWOOD CITY, Calif. --(BUSINESS WIRE)--Sep. 21, 2021-- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally
Aug 26, 2021 Pulmonx to Present at Upcoming September Investor Conferences
REDWOOD CITY, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) today announced the company will be participating in fireside chats at two upcoming virtual investor conferences. Pulmonx management is scheduled to participate in the 2021 Virtual Wells Fargo
Aug 20, 2021 Pulmonx Announces Anthem Blue Cross Blue Shield Now Provides Coverage for Severe COPD/Emphysema Treatment
Positive Coverage Policy Gives Additional 34   Million People Access to Treatment with the Zephyr® Valve, a Minimally Invasive Treatment Option REDWOOD CITY, Calif. --(BUSINESS WIRE)--Aug. 20, 2021-- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments
Aug 03, 2021 Pulmonx Reports Second Quarter 2021 Financial Results
REDWOOD CITY, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for severe lung disease, today reported financial results for the second quarter ended June 30, 2021.
Aug 02, 2021 Pulmonx Welcomes Two New Board Members, Adding Expertise in Health Technology, Consumer Marketing, and Integrated Healthcare Delivery Networks
Alissa Hsu Lynch and Tiffany Sullivan join the Pulmonx Board of Directors REDWOOD CITY, Calif., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG), a global leader in minimally invasive treatments for severe lung disease, welcomes Alissa Hsu Lynch and Tiffany Sullivan to its Board
Jul 29, 2021 Pulmonx to Present at the Canaccord Genuity 41st Annual Growth Conference
REDWOOD CITY, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Canaccord Genuity 41 st Annual Growth
Displaying 1 - 10 of 19
Print Page
Email Alerts
Contact IR
RSS Feeds